🇺🇸 Doxophylline in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 5
Most-reported reactions
- Cardiac Discomfort — 1 report (20%)
- Condition Aggravated — 1 report (20%)
- Mental Disorder — 1 report (20%)
- Pneumonia — 1 report (20%)
- Pneumonitis — 1 report (20%)
Other Other approved in United States
Frequently asked questions
Is Doxophylline approved in United States?
Doxophylline does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Doxophylline in United States?
Universidad Autonoma de Nuevo Leon is the originator. The local marketing authorisation holder may differ — check the official source linked above.